OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
81 hedge funds and large institutions have $100M invested in Osiris Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
96% less call options, than puts
Call options by funds: $162K | Put options by funds: $3.83M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
81
Holding in Top 10
–
Calls
$162K
Puts
$3.83M
Top Buyers
| 1 | +$2.13M | |
| 2 | +$1.21M | |
| 3 | +$996K | |
| 4 |
Renaissance Technologies
New York
|
+$761K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$385K |
Top Sellers
| 1 | -$3.78M | |
| 2 | -$2.19M | |
| 3 | -$1.87M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.39M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.36M |